Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02932306 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
A Phase 3 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 3
- Development phase
- 820
- Enrollment target
NCT02932306 is a Phase 3 study that has completed, run by Bausch Health Americas. The registered enrollment target is 820 participants.
The verdict
NCT02932306, a Phase 3 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 820 participants
- Enrollment target
Study Summary
The objective of this study was to evaluate the efficacy, safety, and tolerability of a once daily topical application of IDP-121 Lotion compared with its vehicle (IDP-121 Vehicle Lotion) in participants with moderate to severe acne vulgaris (acne) (that is, acne having an Evaluator's Global Severity Score \[EGSS\] of 3 \[moderate\] or 4 \[severe\]).
Interventions
- DRUG IDP-121 Vehicle Lotion
- DRUG IDP-121 Lotion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 820 participants |
| Start Date | 2015-11-03 |
| Est. Completion | 2017-02-22 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02932306
The ClinicalTrials.gov registry entry for NCT02932306 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 820 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IDP-121 Vehicle Lotion is the first listed.
NCT02932306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02932306 about?
NCT02932306 is a clinical study titled "Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris". The objective of this study was to evaluate the efficacy, safety, and tolerability of a once daily topical application of IDP-121 Lotion compared with its vehicle (IDP-121 Vehicle Lotion) in participants with moderate to severe acne vulgaris (acne) (that is, acne having an Evaluator's Global Severit...
What is the current status of trial NCT02932306?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 820 participants. The study started on 2015-11-03. Estimated completion is 2017-02-22.
What interventions are being tested in trial NCT02932306?
The interventions under investigation include: IDP-121 Vehicle Lotion (DRUG), IDP-121 Lotion (DRUG).
Who is sponsoring clinical trial NCT02932306?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.